Growth Metrics

Cytosorbents (CTSO) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -38.60%
Dec 31, 2025 81.56%
Sep 30, 2025 -14.54%
Jun 30, 2025 -30.20%
Mar 31, 2025 -11.09%
Dec 31, 2024 3.25%
Sep 30, 2024 -9.91%
Jun 30, 2024 3.08%
Mar 31, 2024 -42.49%
Dec 31, 2023 53.62%
Sep 30, 2023 90.53%
Jun 30, 2023 -31.33%
Mar 31, 2023 -4.54%
Dec 31, 2022 -13.48%
Sep 30, 2022 32.06%
Jun 30, 2022 -3.35%
Mar 31, 2022 -1.17%
Dec 31, 2021 -20.25%
Sep 30, 2021 -35.88%
Jun 30, 2021 0.00%
Mar 31, 2021 -38.15%
Dec 31, 2020 131.53%
Sep 30, 2020 4.02%
Jun 30, 2020 43.40%
Mar 31, 2020 48.55%
Dec 31, 2019 -38.78%
Sep 30, 2019 453.10%
Jun 30, 2019 -36.31%
Mar 31, 2019 -85.53%
Dec 31, 2018 474.27%
Sep 30, 2018 -86.74%
Jun 30, 2018 851.11%
Mar 31, 2018 -85.15%
Dec 31, 2017 52.39%
Sep 30, 2017 20.20%
Jun 30, 2017 765.52%
Mar 31, 2017 131.53%
Dec 31, 2016 -335.54%
Sep 30, 2016 -74.78%
Jun 30, 2016 360.10%
Mar 31, 2016 -12.26%
Dec 31, 2015 7.25%
Sep 30, 2015 37.36%
Jun 30, 2015 30.31%
Sep 30, 2014 58.45%
Jun 30, 2014 -17.23%
Mar 31, 2014 -85.34%
Dec 31, 2013 294.74%
Sep 30, 2013 -595.25%
Jun 30, 2013 -82.03%
Mar 31, 2013 389.34%
Dec 31, 2012 271.33%
Sep 30, 2012 210.80%
Jun 30, 2012 651.88%
Mar 31, 2012 -99.85%
Dec 31, 2011 8.32%
Sep 30, 2011 16,771.17%
Jun 30, 2011 -98.89%
Mar 31, 2011 332.38%
Dec 31, 2010 104.18%